Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS). | MicrobiomeTrials← Back to trialsNCT07107022
Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS).
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-11-01Est. Completion: 2028-01
Enrollment target: 200 participants Locations- Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
- CHU de Bordeaux - Hôpital Pellegrin, Bordeaux, France
- CHU de Brest - Hôpital de la Cavale Blanche, Brest, France
- Hôpital Pierre-Paul Riquet, Toulouse, France
- TUM Klinikum rechts der Isar, München, Bavaria, Germany
- Knappschaft Kliniken Vest Recklinghausen, Recklinghausen, Westphalia, Germany
- Universitätsklinikum Augsburg, Augsburg, Germany
- Universitätsklinikum Schleswig-Holstein (UKSH) Lübeck, Lübeck, Germany
- Universitätsspital Basel, Basel, Basel-Landschaft, Switzerland
- Inselspital Universitätsklinik für Neurologie, Bern, Switzerland
Other microbiome trials you might be interested in
Acute Ischemic Stroke AIS
This is a Phase IIa clinical trial with a three-arm design that utilizes randomization, double-blinding, and placebo con…
Beijing, ChinaEst. completion May 31, 2027
Acute Ischemic Stroke (AIS)
Acute ischemic stroke caused by blockage of a large artery in the brain is one of the leading causes of death and long-t…
Suzhou, ChinaEst. completion May 31, 2028